Postpartum Hemorrhage Management Guidelines
Definition and Initial Recognition
- Postpartum hemorrhage is defined as blood loss ≥500 mL after vaginal delivery or ≥1000 mL after caesarean section, or any blood loss sufficient to compromise hemodynamic stability 1, 2
- PPH is the leading cause of maternal mortality globally, with most deaths occurring within the first 24 hours after birth 1
Immediate First-Line Management
- Administer intravenous tranexamic acid 1 g over 10 minutes within 3 hours of birth alongside oxytocin 5-10 IU (IV or IM), initiate uterine massage and bimanual compression, and begin fluid resuscitation with physiologic electrolyte solutions 1, 3
- TXA must be given within 3 hours of birth—effectiveness decreases by approximately 10% for every 15-minute delay, and administration beyond 3 hours may be harmful 1, 3
- A second dose of 1 g should be given if bleeding continues after 30 minutes or restarts within 24 hours 1, 3
Mechanical Interventions
- Intrauterine balloon tamponade should be implemented if pharmacological management fails, with success rates of 79-90% when properly placed 1, 3
- Pelvic pressure packing is effective for acute uncontrolled hemorrhage stabilization and can remain for 24 hours 2, 3
Resuscitation and Blood Product Management
- Initiate massive transfusion protocol if blood loss exceeds 1,500 mL, transfusing packed RBCs, fresh frozen plasma, and platelets in fixed ratio 2, 3
- Target hemoglobin >8 g/dL and fibrinogen ≥2 g/L during active hemorrhage 3
- Do not delay transfusion waiting for laboratory results in severe bleeding 2, 3
Etiology-Specific Considerations
- Uterine atony is treated with uterotonic drugs and uterine massage as described above 3
- Trauma requires careful visual inspection and surgical repair 3
- Retained placenta/products should be diagnosed with ultrasound and treated with surgical evacuation if confirmed 2, 3
Monitoring and Post-Acute Care
- Continue hemodynamic monitoring for at least 24 hours post-delivery due to significant fluid shifts that may precipitate heart failure in women with structural heart disease 1, 3
- Monitor for complications such as renal failure, liver failure, infection, and Sheehan syndrome 2, 3
Special Populations
- Anticoagulated patients with mechanical heart valves should switch from oral anticoagulants to LMWH/UFH from 36 weeks gestation and discontinue UFH 4-6 hours before planned delivery 3
Critical Pitfalls to Avoid
- Delaying TXA administration beyond 3 hours or waiting to give it—every 15-minute delay reduces effectiveness by 10% 1, 3
- Delaying treatment for active hemorrhage while waiting for laboratory results 2
- Failing to maintain normothermia and normal pH, which impairs clotting 2, 3
- Using methylergonovine in hypertensive patients 3
- Routine manual removal of placenta in non-severe cases 5, 1